FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
Stocktwits on MSN
ASBP stock soars 32% after favorable feedback from FDA for its aspirin – retail expects licensing negotiations soon
Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...
The Chosun Ilbo on MSN
Trump's 325 mg aspirin habit sparks medical alarms
U.S. President Donald Trump recently revealed that he has been taking 325 mg of aspirin daily for over 20 years, prompting ...
The problem with daily aspirin use is the risk of bleeding, as seen time and time again in major randomized trials. In the ...
Trump casually dismisses evidence-based recommendations as he attacks panels that makes such recommendations for the American ...
President Donald Trump recently said he takes more aspirin to thin his blood than doctors usually recommend, noting he's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback